showing

iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity PipelineiBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody, could have a human half-life as long as…

4 weeks ago
Woxsen University Releases MBA Placement Report 2025 showing Strong Growth in Industry DemandWoxsen University Releases MBA Placement Report 2025 showing Strong Growth in Industry Demand

Woxsen University Releases MBA Placement Report 2025 showing Strong Growth in Industry Demand

HYDERABAD, India, April 1, 2025 /PRNewswire/ -- Woxsen University has released its MBA Placement Report for the 2023-2025 batch, highlighting…

1 month ago
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to EpidiolexArtelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex

Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex

February 14, 2025 09:00 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

3 months ago